Systematic biomarker discovery and coordinative validation for different primary nephrotic syndromes using gas chromatography-mass spectrometry

Jung Eun Lee, Yu Ho Lee, Se Yun Kim, Yang Gyun Kim, Ju Young Moon, Kyung Hwan Jeong, Tae Won Lee, Chun Gyoo Ihm, Sooah Kim, Kyoung Heon Kim, Dong Ki Kim, Yon Su Kim, Chan Duck Kim, Cheol Whee Park, Do Yup Lee, Sang Ho Lee

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

The goal of this study is to identify systematic biomarker panel for primary nephrotic syndromes from urine samples by applying a non-target metabolite profiling, and to validate their utility in independent sampling and analysis by multiplex statistical approaches. Nephrotic syndrome (NS) is a nonspecific kidney disorder, which is mostly represented by minimal change disease (MCD), focal segmental glomerulosclerosis (FSGS), and membranous glomerulonephritis (MGN). Since urine metabolites may mirror disease-specific functional perturbations in kidney injury, we examined urine samples for distinctive metabolic changes to identify biomarkers for clinical applications. We developed unbiased multi-component covarianced models from a discovery set with 48 samples (12 healthy controls, 12 MCD, 12 FSGS, and 12 MGN). To extensively validate their diagnostic potential, new batch from 54 patients with primary NS were independently examined a year after. In the independent validation set, the model including citric acid, pyruvic acid, fructose, ethanolamine, and cysteine effectively discriminated each NS using receiver operating characteristic (ROC) analysis except MCD-MGN comparison; nonetheless an additional metabolite multi-composite greatly improved the discrimination power between MCD and MGN. Finally, we proposed the re-constructed metabolic network distinctively dysregulated by the different NSs that may deepen comprehensive understanding of the disease mechanistic, and help the enhanced identification of NS and therapeutic plans for future.

Original languageEnglish
Pages (from-to)105-115
Number of pages11
JournalJournal of Chromatography A
Volume1453
DOIs
Publication statusPublished - 2016 Jul 1

Fingerprint

Lipoid Nephrosis
Nephrotic Syndrome
Biomarkers
Membranous Glomerulonephritis
Gas chromatography
Gas Chromatography-Mass Spectrometry
Mass spectrometry
Focal Segmental Glomerulosclerosis
Metabolites
Urine
Kidney
Ethanolamine
Metabolic Networks and Pathways
Fructose
Pyruvic Acid
ROC Curve
Citric Acid
Cysteine
Mirrors
Sampling

Keywords

  • Bioinformatics
  • Biomarker panel
  • Gas-chromatography time-of-flight mass spectrometry
  • Human urine
  • Metabolomics
  • Nephrotic syndrome

ASJC Scopus subject areas

  • Analytical Chemistry
  • Organic Chemistry
  • Biochemistry

Cite this

Systematic biomarker discovery and coordinative validation for different primary nephrotic syndromes using gas chromatography-mass spectrometry. / Lee, Jung Eun; Lee, Yu Ho; Kim, Se Yun; Kim, Yang Gyun; Moon, Ju Young; Jeong, Kyung Hwan; Lee, Tae Won; Ihm, Chun Gyoo; Kim, Sooah; Kim, Kyoung Heon; Kim, Dong Ki; Kim, Yon Su; Kim, Chan Duck; Park, Cheol Whee; Lee, Do Yup; Lee, Sang Ho.

In: Journal of Chromatography A, Vol. 1453, 01.07.2016, p. 105-115.

Research output: Contribution to journalArticle

Lee, JE, Lee, YH, Kim, SY, Kim, YG, Moon, JY, Jeong, KH, Lee, TW, Ihm, CG, Kim, S, Kim, KH, Kim, DK, Kim, YS, Kim, CD, Park, CW, Lee, DY & Lee, SH 2016, 'Systematic biomarker discovery and coordinative validation for different primary nephrotic syndromes using gas chromatography-mass spectrometry', Journal of Chromatography A, vol. 1453, pp. 105-115. https://doi.org/10.1016/j.chroma.2016.05.058
Lee, Jung Eun ; Lee, Yu Ho ; Kim, Se Yun ; Kim, Yang Gyun ; Moon, Ju Young ; Jeong, Kyung Hwan ; Lee, Tae Won ; Ihm, Chun Gyoo ; Kim, Sooah ; Kim, Kyoung Heon ; Kim, Dong Ki ; Kim, Yon Su ; Kim, Chan Duck ; Park, Cheol Whee ; Lee, Do Yup ; Lee, Sang Ho. / Systematic biomarker discovery and coordinative validation for different primary nephrotic syndromes using gas chromatography-mass spectrometry. In: Journal of Chromatography A. 2016 ; Vol. 1453. pp. 105-115.
@article{42cda2d97b9d4bf4a5f50d9a3ed474e0,
title = "Systematic biomarker discovery and coordinative validation for different primary nephrotic syndromes using gas chromatography-mass spectrometry",
abstract = "The goal of this study is to identify systematic biomarker panel for primary nephrotic syndromes from urine samples by applying a non-target metabolite profiling, and to validate their utility in independent sampling and analysis by multiplex statistical approaches. Nephrotic syndrome (NS) is a nonspecific kidney disorder, which is mostly represented by minimal change disease (MCD), focal segmental glomerulosclerosis (FSGS), and membranous glomerulonephritis (MGN). Since urine metabolites may mirror disease-specific functional perturbations in kidney injury, we examined urine samples for distinctive metabolic changes to identify biomarkers for clinical applications. We developed unbiased multi-component covarianced models from a discovery set with 48 samples (12 healthy controls, 12 MCD, 12 FSGS, and 12 MGN). To extensively validate their diagnostic potential, new batch from 54 patients with primary NS were independently examined a year after. In the independent validation set, the model including citric acid, pyruvic acid, fructose, ethanolamine, and cysteine effectively discriminated each NS using receiver operating characteristic (ROC) analysis except MCD-MGN comparison; nonetheless an additional metabolite multi-composite greatly improved the discrimination power between MCD and MGN. Finally, we proposed the re-constructed metabolic network distinctively dysregulated by the different NSs that may deepen comprehensive understanding of the disease mechanistic, and help the enhanced identification of NS and therapeutic plans for future.",
keywords = "Bioinformatics, Biomarker panel, Gas-chromatography time-of-flight mass spectrometry, Human urine, Metabolomics, Nephrotic syndrome",
author = "Lee, {Jung Eun} and Lee, {Yu Ho} and Kim, {Se Yun} and Kim, {Yang Gyun} and Moon, {Ju Young} and Jeong, {Kyung Hwan} and Lee, {Tae Won} and Ihm, {Chun Gyoo} and Sooah Kim and Kim, {Kyoung Heon} and Kim, {Dong Ki} and Kim, {Yon Su} and Kim, {Chan Duck} and Park, {Cheol Whee} and Lee, {Do Yup} and Lee, {Sang Ho}",
year = "2016",
month = "7",
day = "1",
doi = "10.1016/j.chroma.2016.05.058",
language = "English",
volume = "1453",
pages = "105--115",
journal = "Journal of Chromatography",
issn = "0021-9673",
publisher = "Elsevier",

}

TY - JOUR

T1 - Systematic biomarker discovery and coordinative validation for different primary nephrotic syndromes using gas chromatography-mass spectrometry

AU - Lee, Jung Eun

AU - Lee, Yu Ho

AU - Kim, Se Yun

AU - Kim, Yang Gyun

AU - Moon, Ju Young

AU - Jeong, Kyung Hwan

AU - Lee, Tae Won

AU - Ihm, Chun Gyoo

AU - Kim, Sooah

AU - Kim, Kyoung Heon

AU - Kim, Dong Ki

AU - Kim, Yon Su

AU - Kim, Chan Duck

AU - Park, Cheol Whee

AU - Lee, Do Yup

AU - Lee, Sang Ho

PY - 2016/7/1

Y1 - 2016/7/1

N2 - The goal of this study is to identify systematic biomarker panel for primary nephrotic syndromes from urine samples by applying a non-target metabolite profiling, and to validate their utility in independent sampling and analysis by multiplex statistical approaches. Nephrotic syndrome (NS) is a nonspecific kidney disorder, which is mostly represented by minimal change disease (MCD), focal segmental glomerulosclerosis (FSGS), and membranous glomerulonephritis (MGN). Since urine metabolites may mirror disease-specific functional perturbations in kidney injury, we examined urine samples for distinctive metabolic changes to identify biomarkers for clinical applications. We developed unbiased multi-component covarianced models from a discovery set with 48 samples (12 healthy controls, 12 MCD, 12 FSGS, and 12 MGN). To extensively validate their diagnostic potential, new batch from 54 patients with primary NS were independently examined a year after. In the independent validation set, the model including citric acid, pyruvic acid, fructose, ethanolamine, and cysteine effectively discriminated each NS using receiver operating characteristic (ROC) analysis except MCD-MGN comparison; nonetheless an additional metabolite multi-composite greatly improved the discrimination power between MCD and MGN. Finally, we proposed the re-constructed metabolic network distinctively dysregulated by the different NSs that may deepen comprehensive understanding of the disease mechanistic, and help the enhanced identification of NS and therapeutic plans for future.

AB - The goal of this study is to identify systematic biomarker panel for primary nephrotic syndromes from urine samples by applying a non-target metabolite profiling, and to validate their utility in independent sampling and analysis by multiplex statistical approaches. Nephrotic syndrome (NS) is a nonspecific kidney disorder, which is mostly represented by minimal change disease (MCD), focal segmental glomerulosclerosis (FSGS), and membranous glomerulonephritis (MGN). Since urine metabolites may mirror disease-specific functional perturbations in kidney injury, we examined urine samples for distinctive metabolic changes to identify biomarkers for clinical applications. We developed unbiased multi-component covarianced models from a discovery set with 48 samples (12 healthy controls, 12 MCD, 12 FSGS, and 12 MGN). To extensively validate their diagnostic potential, new batch from 54 patients with primary NS were independently examined a year after. In the independent validation set, the model including citric acid, pyruvic acid, fructose, ethanolamine, and cysteine effectively discriminated each NS using receiver operating characteristic (ROC) analysis except MCD-MGN comparison; nonetheless an additional metabolite multi-composite greatly improved the discrimination power between MCD and MGN. Finally, we proposed the re-constructed metabolic network distinctively dysregulated by the different NSs that may deepen comprehensive understanding of the disease mechanistic, and help the enhanced identification of NS and therapeutic plans for future.

KW - Bioinformatics

KW - Biomarker panel

KW - Gas-chromatography time-of-flight mass spectrometry

KW - Human urine

KW - Metabolomics

KW - Nephrotic syndrome

UR - http://www.scopus.com/inward/record.url?scp=84969930632&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84969930632&partnerID=8YFLogxK

U2 - 10.1016/j.chroma.2016.05.058

DO - 10.1016/j.chroma.2016.05.058

M3 - Article

C2 - 27247212

AN - SCOPUS:84969930632

VL - 1453

SP - 105

EP - 115

JO - Journal of Chromatography

JF - Journal of Chromatography

SN - 0021-9673

ER -